357 related articles for article (PubMed ID: 19389828)
1. (Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation.
Satofuka S; Ichihara A; Nagai N; Noda K; Ozawa Y; Fukamizu A; Tsubota K; Itoh H; Oike Y; Ishida S
Diabetes; 2009 Jul; 58(7):1625-33. PubMed ID: 19389828
[TBL] [Abstract][Full Text] [Related]
2. (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system.
Satofuka S; Ichihara A; Nagai N; Noda K; Ozawa Y; Fukamizu A; Tsubota K; Itoh H; Oike Y; Ishida S
Am J Pathol; 2008 Dec; 173(6):1911-8. PubMed ID: 18974301
[TBL] [Abstract][Full Text] [Related]
3. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
4. Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization.
Satofuka S; Ichihara A; Nagai N; Koto T; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Itoh H; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):422-9. PubMed ID: 17197563
[TBL] [Abstract][Full Text] [Related]
5. Receptor-associated prorenin system in the pathogenesis of retinal diseases.
Satofuka S; Kanda A; Ishida S
Front Biosci (Schol Ed); 2012 Jun; 4(4):1449-60. PubMed ID: 22652885
[TBL] [Abstract][Full Text] [Related]
6. Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin.
Satofuka S; Ichihara A; Nagai N; Yamashiro K; Koto T; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Suzuki F; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2686-92. PubMed ID: 16723487
[TBL] [Abstract][Full Text] [Related]
7. [Lifestyle-related diseases and anti-aging ophthalmology: suppression of retinal and choroidal pathologies by inhibiting renin-angiotensin system and inflammation].
Ishida S
Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):403-22; discussion 423. PubMed ID: 19348185
[TBL] [Abstract][Full Text] [Related]
8. [Role of (pro)renin receptor in diabetic retinopathy].
Satofuka S
Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):1015-24. PubMed ID: 22171507
[TBL] [Abstract][Full Text] [Related]
9. Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor.
Nagai N; Oike Y; Noda K; Urano T; Kubota Y; Ozawa Y; Shinoda H; Koto T; Shinoda K; Inoue M; Tsubota K; Yamashiro K; Suda T; Ishida S
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2925-31. PubMed ID: 16043867
[TBL] [Abstract][Full Text] [Related]
10. Prorenin induces ERK activation in endothelial cells to enhance neovascularization independently of the renin-angiotensin system.
Uraoka M; Ikeda K; Nakagawa Y; Koide M; Akakabe Y; Nakano-Kurimoto R; Takahashi T; Matoba S; Yamada H; Okigaki M; Matsubara H
Biochem Biophys Res Commun; 2009 Dec; 390(4):1202-7. PubMed ID: 19879243
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina.
Kurihara T; Ozawa Y; Nagai N; Shinoda K; Noda K; Imamura Y; Tsubota K; Okano H; Oike Y; Ishida S
Diabetes; 2008 Aug; 57(8):2191-8. PubMed ID: 18487452
[TBL] [Abstract][Full Text] [Related]
12. (Pro)renin receptor: Involvement in diabetic retinopathy and development of molecular targeted therapy.
Kanda A; Ishida S
J Diabetes Investig; 2019 Jan; 10(1):6-17. PubMed ID: 29575757
[TBL] [Abstract][Full Text] [Related]
13. Pathologic Roles of Receptor-Associated Prorenin System in Idiopathic Epiretinal Membrane.
Dong Y; Kanda A; Noda K; Saito W; Ishida S
Sci Rep; 2017 Mar; 7():44266. PubMed ID: 28276504
[TBL] [Abstract][Full Text] [Related]
14. Prorenin and the (pro)renin receptor: do they have a pathogenic role in the retina?
Wilkinson-Berka JL; Miller AG; Fletcher EL
Front Biosci (Elite Ed); 2010 Jun; 2(3):1054-64. PubMed ID: 20515775
[TBL] [Abstract][Full Text] [Related]
15. Prorenin stimulates a pro-angiogenic and pro-inflammatory response in retinal endothelial cells and an M1 phenotype in retinal microglia.
Zhu T; Miller AG; Deliyanti D; Berka DR; Agrotis A; Campbell DJ; Wilkinson-Berka JL
Clin Exp Pharmacol Physiol; 2015 May; 42(5):537-48. PubMed ID: 25707593
[TBL] [Abstract][Full Text] [Related]
16. Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.
Batenburg WW; Verma A; Wang Y; Zhu P; van den Heuvel M; van Veghel R; Danser AH; Li Q
PLoS One; 2014; 9(6):e100954. PubMed ID: 24968134
[TBL] [Abstract][Full Text] [Related]
17. (Pro)renin receptor blocker improves survival of rats with sepsis.
Hirano Y; Takeuchi H; Suda K; Hagiwara T; Miyasho T; Kawamura Y; Yamada S; Oyama T; Takahashi T; Wada N; Saikawa Y; Ichihara A; Kitagawa Y
J Surg Res; 2014 Jan; 186(1):269-77. PubMed ID: 24011922
[TBL] [Abstract][Full Text] [Related]
18. Effect of the renin inhibitor aliskiren against retinal ischemia-reperfusion injury.
Tenkumo K; Hirooka K; Sherajee SJ; Nakamura T; Itano T; Nitta E; Fujita T; Nishiyama A; Shiraga F
Exp Eye Res; 2014 May; 122():110-8. PubMed ID: 24709336
[TBL] [Abstract][Full Text] [Related]
19. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.
Nagai N; Noda K; Urano T; Kubota Y; Shinoda H; Koto T; Shinoda K; Inoue M; Shiomi T; Ikeda E; Tsubota K; Suda T; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1078-84. PubMed ID: 15728568
[TBL] [Abstract][Full Text] [Related]
20. Activated prorenin as a therapeutic target for diabetic nephropathy.
Ichihara A; Sakoda M; Mito-Kurauchi A; Itoh H
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S63-6. PubMed ID: 18922597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
